+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5446222
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Alere
  • BioHelix
  • Hologica
  • New England Biolabs
  • Nugen
  • Qiagen
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2021: COVID-19 Growth and Change to 2030 provides strategists, marketers and senior management with the critical information they need to assess the global isothermal nucleic acid amplification technology (inaat) market.







The report focuses on the isothermal nucleic acid amplification technology (inaat) market which is experiencing strong growth. The report gives a guide to the isothermal nucleic acid amplification technology (inaat) market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for isothermal nucleic acid amplification technology (inaat)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Isothermal Nucleic Acid Amplification Technology (INAAT) Market Global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope


Markets Covered:


  • By Product: Instrument; Reagent
  • By End-User: Hospital; Reference Laboratories; Others
  • By Technology: NASBA; HAD
  • By Application: Blood Screening; Infectious Disease Diagnostics; Cancer

Companies Mentioned:


Alere; Biomeriux; Qiagen; Becton, Dickinson and Company

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data Segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

What is the estimated value of the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market?

The Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market was estimated to be valued at $2.6 billion in 2021.

What is the growth rate of the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market?

The growth rate of the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market is 11.4%, with an estimated value of $4.0 billion by 2025.

What is the forecasted size of the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market?

The Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market is estimated to be worth $4.0 billion by 2025.

Who are the key companies in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market?

Key companies in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market include Alere, Biomeriux, Qiagen, Becton, Dickinson & Company, Hologica, Lucigen, Quidel Corporation, New England Biolabs and Ustar Biotechnologies.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alere
  • BioHelix
  • Hologica
  • New England Biolabs
  • Nugen
  • Qiagen

1. Executive Summary2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Characteristics3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends and Strategies4. Impact Of COVID-19 On Isothermal Nucleic Acid Amplification Technology (INAAT)
5. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Growth
5.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segmentation
6.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Instrument
  • Reagent
6.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Reference Laboratories
  • Others
6.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • NASBA
  • HAD
6.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Blood Screening
  • Infectious disease diagnostics
  • Cancer

7. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Regional and Country Analysis
7.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market
8.1. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market
9.1. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
9.2. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market
10.1. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market
11.1. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market
12.1. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market
13.1. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market
14.1. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market
15.1. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
15.2. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market
16.1. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market
17.1. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market
18.4. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market
19.1. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
19.2. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market
20.1. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market
21.1. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
21.2. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market
22.1. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
22.2. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market
23.1. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
23.2. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market
24.1. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market
25.1. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
25.2. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market
26.1. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
26.2. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape and Company Profiles
27.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape
27.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Company Profiles
27.2.1. Alere
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Biomeriux
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Qiagen
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Becton
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Dickinson & Company
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Isothermal Nucleic Acid Amplification Technology (INAAT) Market29. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alere
  • BioHelix
  • Hologica
  • New England Biolabs
  • Nugen
  • Qiagen
Major players in the isothermal nucleic acid amplification technology (INAAT) market are Alere, Biomeriux, Qiagen and Becton, Dickinson and Company.

The global isothermal nucleic acid amplification technology (INAAT) market is expected to grow from $2.36 billion in 2020 to $2.62 billion in 2021 at a compound annual growth rate (CAGR) of 11%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $4.03 billion in 2025 at a CAGR of 11.4%.

The isothermal nucleic acid amplification technology (INAAT) market consists of sales of isothermal nucleic acid amplification technologies and related services. The services include only installation and maintenance services offered by equipment manufacturers. Isothermal nucleic acid amplification technologies are used to amplify DNA sequence from two different nucleic acids segments at the constant temperature.

The isothermal nucleic acid amplification technology (INAAT) market covered in this report is segmented by product into instrument, reagent. It is also segmented by end-user into hospital, reference laboratories, others; by technology into NASBA, HAD and by application into blood screening, infectious disease diagnostics, cancer.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The market for isothermal nucleic acid amplification technology is strictly regulated by stringent regulatory policies that govern the functioning, approvals and standards set for the manufacturers of this market. These regulations discourage companies to invest in new products for research and development or enter new markets. For example, the administration of US food and drugs (USFDA) requires multi-laboratory validation of a loop-mediating isothermal amplification which takes twice as much time as the Commission for European regulatory to review the process. Long regulatory procedures delay the scope for further study of the safety and efficacy of devices and affects the operating cycle of the vendors thereby adversely affecting the growth of the market.

Nanostructures are being incorporated to in vitro diagnostics and in vitro rapid diagnostic tests (RDT) in order to improve existing tests and make them more effective or create innovative diagnostic test approaches that are incorporated in point‐of‐care applications. Nanostructures/nanotechnology uses nanoparticles to enhance the action of the drug in treatment and nanotechnology is the design, characterization, production, and application of devices, structures and systems by controlled manipulation of size and shape at the nanometer scale. For instance, a range of RDTs have been developed to diagnose syphilis such as AccuBioTech (Accu-Tell Rapid Syphilis Test), Alere, Inc. (Alere Determine), Alere/Standard Diagnostics (SD Syphilis 3.0), The Tulip Group/Qualpro (Syphicheck - WB), Cypress Diagnostics (Syphilis Rapid Test), and Omega Diagnostics (Visitect Syphilis). These RDTs allow patients to be diagnosed at the point-of-care (POC).

In 2018, Tecan, a laboratory instruments and solutions provider acquired Nugen Technologies for $54.5 million. The acquisition helps Tecan expand into new market segment of next-generation sequencing (NGS) reagents. Nugen Technologies is a biotech company founded in the year 2000. The U.S. based company having its headquarters in California, manufactures molecular biology reagents for next-generation sequencing genomic analysis.

The incidence of infectious diseases such as H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB are increasing and require isothermal nucleic acid amplification technology (INAAT) to diagnose them. For instance, according to World Health Organization 17 million people lose their lives to infectious diseases every year. Another report by Centers for Disease Control show that number of diseases from mosquitoes, ticks and fleas like West Nile, Zika, Malaria and Lyme disease increased three times. Similarly, as per a survey done by NCBI, around 50% of the population in the United States (approx. 157 million) was suffering from at least one chronic disease in 2020. Increase in infectious or chronic disease drives the demand for diagnosing through isothermal nucleic acid amplification technology.

The isothermal nucleic acid amplification technology market is regulated by government agencies such as European Medicines Agency (EMA), USFDA (the US food and drug ministration), and others. For instance, according to USFDA, each medical device is classified into three groups which is class 1, class 2 & class 3. Class 1 devices require less regulatory control and class 3 requires the most. However, devices which are not been marketed before as in the case of INAAT devices, will fall under class 3 devices as per the medical device amendment. Such devices require approval of a Pre-Market Application (PMA) under the federal law. Premarket approval (PMA) is the scientific and regulatory review process of the FDA to assess the safety and efficacy of medical devices of Class 3.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Alere
  • Biomeriux
  • Qiagen
  • Becton, Dickinson & Company
  • Hologica
  • Lucigen
  • Quidel Corporation
  • New England Biolabs
  • Nugen
  • Ustar Biotechnologies
  • Thermo Fisher Scientific
  • BioHelix
  • Meridian Bioscience
  • New England Biolabs Inc.
  • Novartis Diagnostics
  • Sharp Corp
  • Sony Corp
  • Panasonic
  • Toshiba Corp
  • Rohm
  • PhilipsHologic-Gen-Probe
  • BetaLED
  • Avago technologies
  • Grifols
Note: Product cover images may vary from those shown

Loading
LOADING...